KCM
AZN icon

Kornitzer Capital Management’s AstraZeneca AZN Stock Holding History

Kornitzer Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.2M Buy
148,906
+1,897
+1% +$357K 0.59% 41
2026
Q1 		$29M Buy
147,009
+120
+0.1% +$23.1K 0.62% 38
2025
Q4 		$27M Sell
146,889
-2,000
-1% -$351K 0.56% 39
2025
Q3 		$22.8M Buy
148,889
+3,277
+2% +$496K 0.46% 50
2025
Q2 		$20.4M Sell
145,612
-1,943
-1% -$272K 0.41% 58
2025
Q1 		$21.7M Sell
147,555
-2,146
-1% -$310K 0.45% 54
2024
Q4 		$19.6M Sell
149,701
-30,455
-17% -$4.26M 0.38% 64
2024
Q3 		$28.1M Buy
180,156
+515
+0.3% +$83.1K 0.52% 43
2024
Q2 		$28M Buy
179,641
+436
+0.2% +$65.6K 0.53% 41
2024
Q1 		$24.3M Buy
179,205
+17,222
+11% +$2.28M 0.45% 53
2023
Q4 		$21.8M Buy
161,983
+7,501
+5% +$975K 0.42% 53
2023
Q3 		$20.9M Sell
154,482
-2,070
-1% -$283K 0.43% 46
2023
Q2 		$22.4M Sell
156,552
-917
-0.6% -$135K 0.44% 50
2023
Q1 		$21.9M Sell
157,469
-2,754
-2% -$371K 0.44% 55
2022
Q4 		$21.7M Sell
160,223
-365
-0.2% -$45.8K 0.44% 55
2022
Q3 		$17.6M Sell
160,588
-6,174
-4% -$783K 0.38% 69
2022
Q2 		$22M Buy
166,762
+465
+0.3% +$61K 0.44% 58
2022
Q1 		$22.1M Buy
166,297
+22,395
+16% +$2.69M 0.36% 84
2021
Q4 		$16.8M Sell
143,902
-750
-0.5% -$88.2K 0.25% 154
2021
Q3 		$17.4M Sell
144,652
-11,627
-7% -$1.35M 0.27% 144
2021
Q2 		$18.7M Buy
156,279
+20,962
+15% +$2.3M 0.28% 139
2021
Q1 		$13.5M Buy
135,317
+4,076
+3% +$410K 0.22% 183
2020
Q4 		$13.1M Buy
131,241
+84,212
+179% +$8.92M 0.22% 163
2020
Q3 		$5.15M Hold
47,029
– – 0.1% 254
2020
Q2 		$4.97M Buy
47,029
+2,529
+6% +$261K 0.1% 253
2020
Q1 		$3.98M Sell
44,500
-3,035
-6% -$286K 0.09% 246
2019
Q4 		$4.74M Buy
47,535
+5,985
+14% +$563K 0.08% 260
2019
Q3 		$3.7M Buy
41,550
+13,500
+48% +$1.17M 0.07% 281
2019
Q2 		$2.32M Buy
28,050
+6,350
+29% +$498K 0.04% 321
2019
Q1 		$1.75M Buy
+21,700
New +$1.71M 0.03% 332

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
ISS
Intesa Sanpaolo SpA. Turin, Italy $2.92B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Kornitzer Capital Management's AZN Position: Q2 2026 in Review

Kornitzer Capital Management increased its AstraZeneca (AZN) stake by 1.3% in Q2 2026, buying an estimated $357K and bringing the position to 148,906 shares worth $28.2M. The position accounts for 0.59% of the portfolio, ranked #41.

Kornitzer Capital Management first reported a position in AZN in Q1 2019 and has held it in 30 quarters since. The position peaked at $29M in Q1 2026. 655 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Kornitzer Capital Management held 148,906 shares of AstraZeneca worth $28.2M as of Q2 2026.
  • Kornitzer Capital Management bought 1,897 AstraZeneca shares in Q2 2026, an estimated $357K.
  • AstraZeneca made up 0.59% of Kornitzer Capital Management's portfolio in Q2 2026, its #41 holding.
  • Kornitzer Capital Management first reported a position in AstraZeneca in Q1 2019 and has held it in 30 quarters since.
  • Kornitzer Capital Management's AstraZeneca position peaked at $29M in Q1 2026.
  • 655 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Kornitzer Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.